Daniel Chen

Partner & Co-Founder Genesis BioCapital

Seminars

Wednesday 5th November 2025
Summary Panel Discussion: Exploring ADC Clinical Performance & Improving Clinical Design to Reach Meaningful Patient Benefit for ADCs
3:00 pm

Join the clinical and medical presenters to review the key learnings from the scientific program days. Be sure to bring any questions across ADC clinical development strategy and streamlining clinical design and operations to unlock ADC differentiation in a crowded clinical landscape

Wednesday 5th November 2025
Lessons From ADC Clinical Trials: Exploring Human Biology, “Synthetic Lethality” & Future ADC Design
11:00 am
  • Reviewing the successes and failures for ADCs in the clinic in categories across target, indication, ADC design and linker payload
  • Understanding implications for human biology and how this relates to improvement opportunities for ADCs
  • Laying out lessons for mechanism of action of ORR versus CR/DOR

Wednesday 5th November 2025
Chair:

Download the Full Event Guide for full details

Daniel Chen